Reporting of Good and Bad News: Case of the Pharmaceutical Industry
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F25940082%3A_____%2F19%3AN0000041" target="_blank" >RIV/25940082:_____/19:N0000041 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Reporting of Good and Bad News: Case of the Pharmaceutical Industry
Original language description
Corporate narratives now play a crucial role in the company’s annual reporting, being a good source of information for shareholders to track the company’s performance. These narratives, however, are not regulated and are often an opportunity for companies to employ impression management techniques. The purpose of this research is to investigate the different disclosure strategies that organizations undertake, specifically regarding good aspects of their performance versus bad ones. The aim is to answer the research question – “What impression management tactics are companies using when reporting good vs bad news?”. Using a case study approach, the subject of this research is the European pharmaceutical industry, specifically three of the top companies – Bayer, GlaxoSmithKline, and Novartis. The data chosen for research are the letters to shareholders from each of the companies’ ten latest annual reports (2009-2018). The first part of the research involved coding the good and bad news in the letters to shareholders, following a predetermined coding rationale. These codings were then carefully analyzed to determine whether any impression management techniques were present. The main identified tactics are: stressing the positive and downplaying the negative, differential reporting, attribution, and competence enhancement. Additional impression management tactics, not necessarily pertaining to good and bad news, include ingratiation and the use of emotion. The implications drawn from this research are that the shareholders, and stakeholders in general, need to be vigilant when reading the corporate narratives, to discern when the meaning of the text is somehow manipulated to manage their impressions of the companies.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
—
OECD FORD branch
50205 - Accounting
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
7th International Scientific Conference on IFRS - Global Rules and Local Use - Beyond the Numbers
ISBN
978-80-907602-0-2
ISSN
—
e-ISSN
—
Number of pages
21
Pages from-to
148-168
Publisher name
Anglo-American University
Place of publication
Praha
Event location
Praha
Event date
Oct 10, 2019
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
000649685400012